Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study
Related Posts
Hoque A, Kinninger A, Roy SK, Budoff M. Coronary Plaque Burden and Progression in Los Angeles Firefighters Versus Matched Controls: A Cohort Study. J Occup[...]
Bhatia HS, Razavi AC, Dardari Z, McClelland RL, Jacobs DR Jr, Terry JG, Carr JJ, Duprez D, Joshi PH, Rohatgi A, Khera A, Rana JS,[...]
Won KB, Lee BK, Hadamitzky M, Kim YJ, Sung JM, Conte E, Pontone G, Andreini D, Budoff MJ, Gottlieb I, Chun EJ, Cademartiri F, Maffei[...]